IMC

WSE-listed Ukrainian agricultural producer IMC reported 1Q26 sales of $44m (-13% y-o-y), EBITDA of $3m (-68% y-o-y), and a net loss of $5m, down from a $1m net profit in 1Q25. End-1Q26 financial debt (before $124m of lease liabilities under IFRS 16) halved y-o-y to $11m, implying a net cash position of $17m (-22% y-o-y).

WSE-listed Ukrainian agricultural producer IMC reported 2025 sales of $190m (-10% y-o-y), a gain from the change in fair value of biological assets (IAS 41) of $92m (+22%), EBITDA of $96m (+11%), and net income of $68m (+24%). End-2025 total debt stood at $135m, up 5% y-o-y, while the cash position was broadly unchanged y-o-y at $45m. Financial debt (before $117m of lease liabilities under IFRS 16) thus amounted to $18m, down 23% y-o-y, implying net cash of $27m.